Riskpilot← Back to searchSign inGet full accessLægerne Danmark ApS
APSActiveCVR 41770864Philip Heymans Alle 17General medical practice activities · NACE 8621Est. 20202 employeeslaegernedanmark.dk
Revenue 2025
DKK -51K
-107% vs 2024
EBITDA margin
2284.4%
-590% vs 2024
Equity ratio
14.6%
Financial strength
Net profit 2025
DKK -895K
-461% vs 2024
| Revenue | DKK -51K | -107% |
| EBITDA | DKK -1,2M | -590% |
| Net profit | DKK -895K | -461% |
| Total assets | DKK 1,4M | -2% |
| Equity | DKK 203K | -82% |
| Employees | 2 | — |
Legal name
Lægerne Danmark ApS
CVR number
41770864
Legal form
Anpartsselskab
NACE code
8621 · General medical practice activities
Founded
16. oktober 2020
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er at drive udviklingsvirksomhed, virksomhed med levering af sundhedsfaglige ydelser og hermed beslægtet virksomhed efter direktionens skøn
Address
Philip Heymans Alle 17
Phone
+4529641155
Website
laegernedanmark.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7.279 | 16.956 | -1.066 | 748 | -51 |
| Staff expenses | -4.043 | -6.866 | -815 | -511 | -1.083 |
| EBITDA | 3.236 | 10.090 | -1.881 | 236 | -1.158 |
| Depreciation & amort. | -12 | -18 | -0 | -0 | -0 |
| EBIT | 3.224 | 10.072 | -1.881 | 236 | -1.158 |
| Net financials | -15 | -162 | -74 | 3 | 30 |
| Profit before tax | 3.209 | 9.910 | -1.955 | 239 | -1.128 |
| Tax | 711 | 2.184 | -0 | -9 | -234 |
| Net profit | 2.498 | 7.725 | -1.955 | 248 | -895 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 10.838 | 13.581 | 3.561 | 1.410 | 1.384 |
| Equity | 2.538 | 7.864 | 907 | 1.097 | 203 |
| Long-term debt | 712 | 2.489 | 0 | 0 | 0 |
| Short-term debt | 7.589 | 3.228 | 2.654 | 313 | 1.181 |
| Total debt | 8.300 | 5.717 | 2.654 | 313 | 1.181 |
EBITDA margin
-115810000.0%
This company
15.8%
Market median
-732974784% vs market
20212025
Equity ratio
14.6%
This company
38.2%
Market median
-62% vs market
20212025
Return on equity
-441.6%
This company
18.4%
Market median
-2500% vs market
20212025
Net profit margin
-89474900.0%
This company
8.1%
Market median
-1104628495% vs market
20212025
Asset turnover
-0.04×
This company
1.12×
Market median
-104% vs market
20212025
Debt / equity
5.83×
This company
0.62×
Market median
-840% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-16 – 2021-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TB Management | Management | 2020 | — | — |
KF Management | Management | 2020 | — | — |
JF Management | Management | 2023 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Fraes Espersen Holding ApS | Company | 100.0% | 100.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fraes Espersen Holding ApS
Lægerne Danmark ApS Board members of Lægerne Danmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Brink Frederiksen | Management | 0 companies |
| Kathrine Fraes Espersen | Management | 0 companies |
| Jakob Fraes Espersen | Management | 0 companies |